• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INTERLOCK-35; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INTERLOCK-35; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number 83786
Device Problem Premature Activation (1484)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/01/2021
Event Type  Injury  
Manufacturer Narrative
(b)(6).
 
Event Description
It was reported that the coil prematurely detached inside the patient's body and additional intervention was needed to remove.An 8mmx40cm interlock-35 coil was selected for use on the iliac artery.During the procedure, it was noted that the coil prematurely detached inside the patient's body.The device was removed from the patient's body using a capture device and the procedure was completed with another of the same device.No complications were reported and the patient was stable post procedure.
 
Manufacturer Narrative
E1 - initial reporter facility name: (b)(6).Device evaluated by mfr: the device was returned for analysis.A delivery wire and introducer sheath were returned for this complaint.The twist lock of the introducer sheath was found opened.The delivery wire was inspected, and no anomalies were noted.The introducer sheath was inspected, and no anomalies were noticed.No damages were found in the device.Microscopic inspection of the delivery wire was performed and revealed that the zap tip has a smooth surface.The interlocking arm was inspected, and no anomalies were noticed.Dimensional inspection of the delivery wire was performed and the measured dimensions were within specification.No issues were identified during the product analysis.
 
Event Description
It was reported that the coil prematurely detached inside the patient's body and additional intervention was needed to remove.An 8mmx40cm interlock-35 coil was selected for use on the iliac artery.During the procedure, it was noted that the coil prematurely detached inside the patient's body.The device was removed from the patient's body using a capture device and the procedure was completed with another of the same device.No complications were reported and the patient was stable post procedure.It was further reported that the physician used a non-boston scientific catheter to deliver the coil.Because the vessel was too tortuous, the coil could not be delivered.It was found detached when it was withdrawing.After withdrawing the coil and the catheter, the physician used an interlock coil to finish the procedure.The patient is stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERLOCK-35
Type of Device
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11939314
MDR Text Key254284942
Report Number2134265-2021-07031
Device Sequence Number1
Product Code KRD
UDI-Device Identifier08714729793014
UDI-Public08714729793014
Combination Product (y/n)N
PMA/PMN Number
K133208
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 07/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/25/2023
Device Model Number83786
Device Catalogue Number83786
Device Lot Number0025269704
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/10/2021
Initial Date Manufacturer Received 05/25/2021
Initial Date FDA Received06/04/2021
Supplement Dates Manufacturer Received06/23/2021
Supplement Dates FDA Received07/09/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CATHETER - CORDIS 5F
Patient Outcome(s) Required Intervention;
Patient Age57 YR
Patient Weight65
-
-